UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical considerations for the management of androgen indifferent prostate cancer

Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.623-637

2021

Volltextzugriff (PDF)

Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case series

Head & neck, 2019-06, Vol.41 (6), p.E99-E103

2019

Volltextzugriff (PDF)

Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction

Frontiers in oncology, 2021-03, Vol.11, p.621591

2021

Volltextzugriff (PDF)

First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study

Frontiers in oncology, 2019-08, Vol.9, p.701-701

2019

Volltextzugriff (PDF)

Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (5), p.392-399

2024

Volltextzugriff (PDF)

Integrative medicine in cancer survivors

Current opinion in oncology, 2017-07, Vol.29 (4), p.235-242

2017

Volltextzugriff (PDF)

69-Year-Old Woman With Fatigue, Dyspnea, and Lower Extremity Pain

Mayo Clinic proceedings, 2019-01, Vol.94 (1), p.149-154

2019

Volltextzugriff (PDF)

Persistent ST-Segment Elevation: A Pandora’s Box

Circulation (New York, N.Y.), 2018-09, Vol.138 (11), p.1166-1168

2018

Volltextzugriff (PDF)

Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary Tale

JNCI : Journal of the National Cancer Institute, 2018-06, Vol.110 (6), p.551-552

2018

Volltextzugriff (PDF)

56-Year-Old Man With Abdominal Pain and Dyspnea

Mayo Clinic proceedings, 2019-04, Vol.94 (4), p.704-708

2019

Volltextzugriff (PDF)

Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments

Cancers, 2023-12, Vol.15 (24), p.5843

2023

Volltextzugriff (PDF)

Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?

Journal of Nuclear Medicine, 2024-05, Vol.65 (5), p.679-685

2024

Volltextzugriff (PDF)

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

European urology focus, 2023-09, Vol.9 (5), p.734-741

2023

Volltextzugriff (PDF)

Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer

American Society of Clinical Oncology educational book, 2021-06, Vol.41 (41), p.e190-e202

2021

Volltextzugriff (PDF)

Incidence, Diagnosis, and Treatment of Cardiac Toxicity From Trastuzumab in Patients With Breast Cancer

Current breast cancer reports, 2017-09, Vol.9 (3), p.173-182

2017

Volltextzugriff (PDF)

Post-ischaemic exuberant left ventricular mass: thrombus vs. tumour—case report

European heart journal : case reports, 2018-09, Vol.2 (3), p.1-7

2018

Volltextzugriff (PDF)

Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers

Current treatment options in cardiovascular medicine, 2018-02, Vol.20 (2), p.18, Article 18

2018

Volltextzugriff (PDF)

Effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with metastatic renal cell carcinoma: A single-center retrospective analysis

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.426-426

2024

Volltextzugriff (PDF)

Impact of renin-angiotensin system inhibitors on response to PD1/L1 inhibitors in patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.424-424

2024

Volltextzugriff (PDF)

56-Year-Old Man With Abdominal Pain and Dyspnea

Mayo Clinic proceedings, 2019-04, Vol.94 (4), p.704

2019

Volltextzugriff (PDF)

Evaluation of the aggressive variant prostate cancer molecular profile (AVPCm) in CLIA environments

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.250-250

2023

Volltextzugriff (PDF)

Unraveling the gene expression signatures with associated clinical outcomes in papillary renal cell carcinoma

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4558-4558

2024

Volltextzugriff (PDF)

The Maverick trial: A phase 2 study of abivertinib in patients (pts) with metastatic castration resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5106-TPS5106

2023

Volltextzugriff (PDF)

Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.196-196

2023

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical considerations for the management of androgen indifferent prostate cancer

Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case series

Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction

First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study

Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy

Integrative medicine in cancer survivors

69-Year-Old Woman With Fatigue, Dyspnea, and Lower Extremity Pain

Persistent ST-Segment Elevation: A Pandora’s Box

A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer

Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary Tale

56-Year-Old Man With Abdominal Pain and Dyspnea

Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments

Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer

Incidence, Diagnosis, and Treatment of Cardiac Toxicity From Trastuzumab in Patients With Breast Cancer

Post-ischaemic exuberant left ventricular mass: thrombus vs. tumour—case report

Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers

Effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with metastatic renal cell carcinoma: A single-center retrospective analysis

Impact of renin-angiotensin system inhibitors on response to PD1/L1 inhibitors in patients with metastatic renal cell carcinoma (mRCC)

56-Year-Old Man With Abdominal Pain and Dyspnea

Evaluation of the aggressive variant prostate cancer molecular profile (AVPCm) in CLIA environments

Unraveling the gene expression signatures with associated clinical outcomes in papillary renal cell carcinoma

The Maverick trial: A phase 2 study of abivertinib in patients (pts) with metastatic castration resistant prostate cancer (mCRPC)

Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC)

Suchergebnisse filtern